Señales en vivo de AADI | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 10:13):

Stats
Volumen de hoy	17 909.00
Volumen promedio	342 690
Capitalización de mercado	50.34M
EPS	$0 ( 2024-03-13 )
Próxima fecha de ganancias	( $-0.660 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.840
ATR14	$0.00600 (0.30%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Desai Neil	Sell	40 000	Common Stock
2024-04-23	Ball Bryan	Sell	0	Common Stock
2024-04-23	Ball Bryan	Sell	147 500	Stock option (right to buy)
2024-04-23	Ball Bryan	Sell	50 000	Stock option (right to buy)
2024-04-23	Ball Bryan	Sell	40 000	Stock option (right to buy)

INSIDER POWER
45.30
Last 94 transactions
Buy: 5 312 775 \| Sell: 1 045 050

Volumen Correlación

Largo: 0.00 (neutral)

Corto: -0.83 (strong negative)

Signal:(39.32) Neutral

Aadi Bioscience, Inc. Correlación

10 Correlaciones Más Positivas
NAKD	0.963
AVIR	0.957
CCSI	0.954
SMSI	0.95
CSGP	0.94
GAMB	0.937
ASYS	0.937
REFI	0.936
NVCT	0.935
TTCF	0.933

10 Correlaciones Más Negativas
MBIN	-0.967
SLMBP	-0.966
PRAA	-0.956
ZIONP	-0.955
VRCA	-0.954
MDXG	-0.953
TIGO	-0.953
PCYG	-0.949
IDCC	-0.949
ADMS	-0.947

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aadi Bioscience, Inc. Correlación - Moneda/Commodity

-0.54
( weak negative )

-0.07
( neutral )

0.00
( neutral )

-0.39
( neutral )

0.00
( neutral )

0.44
( neutral )

Aadi Bioscience, Inc. Finanzas

Annual	2023
Ingresos:	$24.35M
Beneficio Bruto:	$21.55M (88.47 %)
EPS:	$-2.44

FY	2023
Ingresos:	$24.35M
Beneficio Bruto:	$21.55M (88.47 %)
EPS:	$-2.44

FY	2022
Ingresos:	$15.22M
Beneficio Bruto:	$13.88M (91.23 %)
EPS:	$-2.53

FY	2021
Ingresos:	$1.00M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-12.41

Financial Reports:

No articles found.

Aadi Bioscience, Inc.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Actualizaciones en tiempo real para Aadi Bioscience, Inc. [AADI]

Upcoming Earnings Alert